(1 - 21 von 22
)
EG 427 appoints Cornelia Haag-Molkenteller, M.D., Ph.D., asGlobeNewswire
www.globenewswire.com
— Cornelia Haag-Molkenteller, now Chief Medical Officer at EG Dr. Haag-Molkenteller is a board-certified urologist with over 30 years of ...
Urovant Sciences Announces U.S. FDA Approval of ...Sumitomo Pharma America
www.us.sumitomo-pharma.com
... Cornelia Haag-Molkenteller, M.D., Ph.D., chief medical officer of Urovant Sciences. “By successfully treating clinical symptoms, GEMTESA may allow patients ...
EG 427 Appoints Don Haut, Ph.D as Chief Business Officer ...FirstWord Pharma
firstwordpharma.com
— He is the second senior company executive to be US based, complementing Chief Medical Officer Cornelia Haag-Molkenteller, M.D., Ph.D. Dr ...
EG 427 announces final Series A closing, achieving € FirstWord Pharma
firstwordpharma.com
— ... Cornelia Haag-Molkenteller, M.D., Ph.D., Chief Medical Officer of EG “We are finalizing preparations to initiate clinical trials with ...
sortiert nach Relevanz / Datum